Viridian Therapeutics Shares Are Trading Higher After Needham Raised Its Price Target on the Stock From $30 to $38.
Viridian Therapeutics Shares Are Trading Higher After Needham Raised Its Price Target on the Stock From $30 to $38.
Viridian Therapeutics股票以較高價位交易，Needham將該股的目標價從30美元提高至38美元。
Viridian Therapeutics Shares Are Trading Higher After Needham Raised Its Price Target on the Stock From $30 to $38.
在尼德姆將該股的目標股價從30美元上調至38美元之後，Viridian Therapeutics的股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間